Global Markets for Membrane Technology for Pharmaceuticals
The global market for membrane technology reached $3.8 billion in 2010, nearly $4.6 billion in 2011, and is forecast to reach $7.3 billion in 2016 after increasing at a compound annual growth rate (CAGR) of 9.9%.
SCOPE AND FORMAT
The study is intended for individuals requiring an in-depth analysis of the life science, pharmaceutical, and biopharmaceutical membrane separation technology industries. It traces significant developments and forecasts important trends, quantifies the various market sectors, and highlights companies active in those areas.
The report will not cover membranes used in the healthcare or medical diagnostics fields, or membranes used in air and gas venting on medical devices.
Peggy S Lehr is the BCC Research analyst of this report. Ms. Lehr holds a BS in Journalism from the University of Colorado, Boulder, and an MS in Communication from the University of Denver. Ms. Lehr has worked in the publishing industry for both for-profit and not-for-profit organizations, and she has completed more than 20 reports for BCC.
The market for membrane technology used in biopharmaceutical discovery, development and commercial production, estimated at $740 million dollars in 2004, is expected to rise at an average annual growth rate (AAGR) of 10.7% to $1.23 billion in 2009.
Sales readily can be tied to increases in R&D spending that has grown by an average of 11% annually from 1993 to 2003, the growing number of biotech drugs in the pipeline and skyrocketing sales of approved biopharmaceticals.
Expanded production capacity for bioprocessing will continue to accelerate growth rates across the spectrum, including membrane-based cell culture systems, microfiltration and ultrafiltration of protein solutions, virus removal, and the production of pharmaceutical-grade makeup water.